APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antigen Self Test Nasal

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antigen Self Test Nasal Market Outlook and Growth Opportunities 2026

4 July 2026216 pages

Choose your research edition.

Industry ResearchAntigen Self Test Nasal Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Antigen Self Test Nasal Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Antigen Self Test Nasal Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antigen Self Test Nasal Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Antigen Self Test Nasal Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Antigen Self Test Nasal market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antigen Self Test Nasal market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antigen Self Test Nasal market include Roche, Watsons, TEST SEA LAB, SD Biosensor, RapiGEN Inc., Rapid Labs Limited, Quidel, Princeton BioMeditech Corporation and Orient Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antigen Self Test Nasal market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antigen Self Test Nasal and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antigen Self Test Nasal sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antigen Self Test Nasal market size, projected growth trends, production technologies, key applications, and end-use industries.

Antigen Self Test Nasal Segment by Company

Roche

Watsons

TEST SEA LAB

SD Biosensor

RapiGEN Inc.

Rapid Labs Limited

Quidel

Princeton BioMeditech Corporation

Orient Gene

OraSure Technologies

LumiraDx

InBios

Heathershaws Compounding Pharmacy

Ellume

CTK Biotech

Clip Health

Celltrion

BioTeke Corporation

BGI

BD

Aidian Oy

ACCESS BIO

Abbott

Antigen Self Test Nasal Segment by Type

Colloidal Gold Immunochromatography

Latex Immunochromatography

Fluorescence Immunochromatography

Others

Antigen Self Test Nasal Segment by Application

Hospital

School

Family

Others

Antigen Self Test Nasal Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antigen Self Test Nasal status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antigen Self Test Nasal market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antigen Self Test Nasal significant trends, drivers, influence factors in global and regions.

6. To analyze Antigen Self Test Nasal competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antigen Self Test Nasal market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antigen Self Test Nasal and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antigen Self Test Nasal.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antigen Self Test Nasal market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antigen Self Test Nasal industry.

Chapter 3: Detailed analysis of Antigen Self Test Nasal manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antigen Self Test Nasal in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antigen Self Test Nasal in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antigen Self Test Nasal Industry Trends Table 2. Antigen Self Test Nasal Industry Drivers Table 3. Antigen Self Test Nasal Industry Opportunities and Challenges Table 4. Antigen Self Test Nasal Industry Restraints Table 5. Global Antigen Self Test Nasal Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antigen Self Test Nasal Revenue Share by Company (2021-2026) Table 7. Global Antigen Self Test Nasal Sales Volume by Company (k units) & (2021-2026) Table 8. Global Antigen Self Test Nasal Sales Volume Share by Company (2021-2026) Table 9. Global Antigen Self Test Nasal Average Price (USD/unit) of Company (2021-2026) Table 10. Global Antigen Self Test Nasal Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antigen Self Test Nasal Key Company Manufacturing Base & Headquarters Table 12. Global Antigen Self Test Nasal Company, Product Type & Application Table 13. Global Antigen Self Test Nasal Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antigen Self Test Nasal by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Colloidal Gold Immunochromatography Table 18. Significant Companies of Latex Immunochromatography Table 19. Significant Companies of Fluorescence Immunochromatography Table 20. Significant Companies of Others Table 21. Global Antigen Self Test Nasal Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Antigen Self Test Nasal Sales Volume by Type (2021-2026) & (k units) Table 23. Global Antigen Self Test Nasal Sales Volume by Type (2027-2032) & (k units) Table 24. Global Antigen Self Test Nasal Sales Volume Share by Type (2021-2026) Table 25. Global Antigen Self Test Nasal Sales Volume Share by Type (2027-2032) Table 26. Global Antigen Self Test Nasal Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Antigen Self Test Nasal Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Antigen Self Test Nasal Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Antigen Self Test Nasal Sales Value Share by Type (2021-2026) Table 30. Global Antigen Self Test Nasal Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of School Table 33. Significant Companies of Family Table 34. Significant Companies of Others Table 35. Global Antigen Self Test Nasal Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Antigen Self Test Nasal Sales Volume by Application (2021-2026) & (k units) Table 37. Global Antigen Self Test Nasal Sales Volume by Application (2027-2032) & (k units) Table 38. Global Antigen Self Test Nasal Sales Volume Share by Application (2021-2026) Table 39. Global Antigen Self Test Nasal Sales Volume Share by Application (2027-2032) Table 40. Global Antigen Self Test Nasal Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Antigen Self Test Nasal Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Antigen Self Test Nasal Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Antigen Self Test Nasal Sales Value Share by Application (2021-2026) Table 44. Global Antigen Self Test Nasal Sales Value Share by Application (2027-2032) Table 45. Global Antigen Self Test Nasal Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Antigen Self Test Nasal Sales by Region (2021-2026) & (k units) Table 47. Global Antigen Self Test Nasal Sales Market Share by Region (2021-2026) Table 48. Global Antigen Self Test Nasal Sales by Region (2027-2032) & (k units) Table 49. Global Antigen Self Test Nasal Sales Market Share by Region (2027-2032) Table 50. Global Antigen Self Test Nasal Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Antigen Self Test Nasal Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Antigen Self Test Nasal Sales Value Share by Region (2021-2026) Table 53. Global Antigen Self Test Nasal Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Antigen Self Test Nasal Sales Value Share by Region (2027-2032) Table 55. Global Antigen Self Test Nasal Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Antigen Self Test Nasal Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Antigen Self Test Nasal Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Antigen Self Test Nasal Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 60. Global Antigen Self Test Nasal Sales Market Share by Country (2021-2026) Table 61. Global Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 62. Global Antigen Self Test Nasal Sales Market Share by Country (2027-2032) Table 63. Global Antigen Self Test Nasal Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Antigen Self Test Nasal Sales Value Market Share by Country (2021-2026) Table 65. Global Antigen Self Test Nasal Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Antigen Self Test Nasal Sales Value Market Share by Country (2027-2032) Table 67. Roche Company Information Table 68. Roche Business Overview Table 69. Roche Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Roche Antigen Self Test Nasal Product Portfolio Table 71. Roche Recent Development Table 72. Watsons Company Information Table 73. Watsons Business Overview Table 74. Watsons Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Watsons Antigen Self Test Nasal Product Portfolio Table 76. Watsons Recent Development Table 77. TEST SEA LAB Company Information Table 78. TEST SEA LAB Business Overview Table 79. TEST SEA LAB Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. TEST SEA LAB Antigen Self Test Nasal Product Portfolio Table 81. TEST SEA LAB Recent Development Table 82. SD Biosensor Company Information Table 83. SD Biosensor Business Overview Table 84. SD Biosensor Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. SD Biosensor Antigen Self Test Nasal Product Portfolio Table 86. SD Biosensor Recent Development Table 87. RapiGEN Inc. Company Information Table 88. RapiGEN Inc. Business Overview Table 89. RapiGEN Inc. Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. RapiGEN Inc. Antigen Self Test Nasal Product Portfolio Table 91. RapiGEN Inc. Recent Development Table 92. Rapid Labs Limited Company Information Table 93. Rapid Labs Limited Business Overview Table 94. Rapid Labs Limited Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Rapid Labs Limited Antigen Self Test Nasal Product Portfolio Table 96. Rapid Labs Limited Recent Development Table 97. Quidel Company Information Table 98. Quidel Business Overview Table 99. Quidel Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Quidel Antigen Self Test Nasal Product Portfolio Table 101. Quidel Recent Development Table 102. Princeton BioMeditech Corporation Company Information Table 103. Princeton BioMeditech Corporation Business Overview Table 104. Princeton BioMeditech Corporation Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Princeton BioMeditech Corporation Antigen Self Test Nasal Product Portfolio Table 106. Princeton BioMeditech Corporation Recent Development Table 107. Orient Gene Company Information Table 108. Orient Gene Business Overview Table 109. Orient Gene Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Orient Gene Antigen Self Test Nasal Product Portfolio Table 111. Orient Gene Recent Development Table 112. OraSure Technologies Company Information Table 113. OraSure Technologies Business Overview Table 114. OraSure Technologies Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. OraSure Technologies Antigen Self Test Nasal Product Portfolio Table 116. OraSure Technologies Recent Development Table 117. LumiraDx Company Information Table 118. LumiraDx Business Overview Table 119. LumiraDx Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. LumiraDx Antigen Self Test Nasal Product Portfolio Table 121. LumiraDx Recent Development Table 122. InBios Company Information Table 123. InBios Business Overview Table 124. InBios Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. InBios Antigen Self Test Nasal Product Portfolio Table 126. InBios Recent Development Table 127. Heathershaws Compounding Pharmacy Company Information Table 128. Heathershaws Compounding Pharmacy Business Overview Table 129. Heathershaws Compounding Pharmacy Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Heathershaws Compounding Pharmacy Antigen Self Test Nasal Product Portfolio Table 131. Heathershaws Compounding Pharmacy Recent Development Table 132. Ellume Company Information Table 133. Ellume Business Overview Table 134. Ellume Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Ellume Antigen Self Test Nasal Product Portfolio Table 136. Ellume Recent Development Table 137. CTK Biotech Company Information Table 138. CTK Biotech Business Overview Table 139. CTK Biotech Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. CTK Biotech Antigen Self Test Nasal Product Portfolio Table 141. CTK Biotech Recent Development Table 142. Clip Health Company Information Table 143. Clip Health Business Overview Table 144. Clip Health Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Clip Health Antigen Self Test Nasal Product Portfolio Table 146. Clip Health Recent Development Table 147. Celltrion Company Information Table 148. Celltrion Business Overview Table 149. Celltrion Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Celltrion Antigen Self Test Nasal Product Portfolio Table 151. Celltrion Recent Development Table 152. BioTeke Corporation Company Information Table 153. BioTeke Corporation Business Overview Table 154. BioTeke Corporation Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. BioTeke Corporation Antigen Self Test Nasal Product Portfolio Table 156. BioTeke Corporation Recent Development Table 157. BGI Company Information Table 158. BGI Business Overview Table 159. BGI Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. BGI Antigen Self Test Nasal Product Portfolio Table 161. BGI Recent Development Table 162. BD Company Information Table 163. BD Business Overview Table 164. BD Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. BD Antigen Self Test Nasal Product Portfolio Table 166. BD Recent Development Table 167. Aidian Oy Company Information Table 168. Aidian Oy Business Overview Table 169. Aidian Oy Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Aidian Oy Antigen Self Test Nasal Product Portfolio Table 171. Aidian Oy Recent Development Table 172. ACCESS BIO Company Information Table 173. ACCESS BIO Business Overview Table 174. ACCESS BIO Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. ACCESS BIO Antigen Self Test Nasal Product Portfolio Table 176. ACCESS BIO Recent Development Table 177. Abbott Company Information Table 178. Abbott Business Overview Table 179. Abbott Antigen Self Test Nasal Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Abbott Antigen Self Test Nasal Product Portfolio Table 181. Abbott Recent Development Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Antigen Self Test Nasal Distributors List Table 185. Antigen Self Test Nasal Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Antigen Self Test Nasal Product Image Figure 2. Global Antigen Self Test Nasal Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antigen Self Test Nasal Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antigen Self Test Nasal Sales (2021-2032) & (k units) Figure 5. Global Antigen Self Test Nasal Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Antigen Self Test Nasal Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Colloidal Gold Immunochromatography Image Figure 10. Latex Immunochromatography Image Figure 11. Fluorescence Immunochromatography Image Figure 12. Others Image Figure 13. Global Antigen Self Test Nasal Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Antigen Self Test Nasal Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Antigen Self Test Nasal Sales Volume Share by Type (2021-2032) Figure 16. Global Antigen Self Test Nasal Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Antigen Self Test Nasal Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Antigen Self Test Nasal Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. School Image Figure 21. Family Image Figure 22. Others Image Figure 23. Global Antigen Self Test Nasal Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Antigen Self Test Nasal Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Antigen Self Test Nasal Sales Volume Share by Application (2021-2032) Figure 26. Global Antigen Self Test Nasal Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antigen Self Test Nasal Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Antigen Self Test Nasal Sales Value Share by Application (2021-2032) Figure 29. Global Antigen Self Test Nasal Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Antigen Self Test Nasal Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Antigen Self Test Nasal Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Antigen Self Test Nasal Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Antigen Self Test Nasal Sales Value (2021-2032) & (US$ Million) Figure 34. North America Antigen Self Test Nasal Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Antigen Self Test Nasal Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Antigen Self Test Nasal Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Antigen Self Test Nasal Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Antigen Self Test Nasal Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Antigen Self Test Nasal Sales Value (2021-2032) & (US$ Million) Figure 40. South America Antigen Self Test Nasal Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Antigen Self Test Nasal Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Antigen Self Test Nasal Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Antigen Self Test Nasal Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Antigen Self Test Nasal Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Antigen Self Test Nasal Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Colloidal Gold Immunochromatography
  • Latex Immunochromatography
  • Fluorescence Immunochromatography
  • Others
Applications
  • Hospital
  • School
  • Family
  • Others
Companies covered
  • Roche
  • Watsons
  • TEST SEA LAB
  • SD Biosensor
  • RapiGEN Inc.
  • Rapid Labs Limited
  • Quidel
  • Princeton BioMeditech Corporation
  • Orient Gene
  • OraSure Technologies
  • LumiraDx
  • InBios
  • Heathershaws Compounding Pharmacy
  • Ellume
  • CTK Biotech
  • Clip Health
  • Celltrion
  • BioTeke Corporation
  • BGI
  • BD
  • Aidian Oy
  • ACCESS BIO
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antigen Self Test Nasal Sales Value (2021-2032)
  4. 1.2.2 Global Antigen Self Test Nasal Sales Volume (2021-2032)
  5. 1.2.3 Global Antigen Self Test Nasal Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antigen Self Test Nasal Market Dynamics
  1. 2.1 Antigen Self Test Nasal Industry Trends
  2. 2.2 Antigen Self Test Nasal Industry Drivers
  3. 2.3 Antigen Self Test Nasal Industry Opportunities and Challenges
  4. 2.4 Antigen Self Test Nasal Industry Restraints
3 Antigen Self Test Nasal Market by Company
  1. 3.1 Global Antigen Self Test Nasal Company Revenue Ranking in 2025
  2. 3.2 Global Antigen Self Test Nasal Revenue by Company (2021-2026)
  3. 3.3 Global Antigen Self Test Nasal Sales Volume by Company (2021-2026)
  4. 3.4 Global Antigen Self Test Nasal Average Price by Company (2021-2026)
  5. 3.5 Global Antigen Self Test Nasal Company Ranking (2024-2026)
  6. 3.6 Global Antigen Self Test Nasal Company Manufacturing Base and Headquarters
  7. 3.7 Global Antigen Self Test Nasal Company Product Type and Application
  8. 3.8 Global Antigen Self Test Nasal Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antigen Self Test Nasal Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antigen Self Test Nasal Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antigen Self Test Nasal Market by Type
  1. 4.1 Antigen Self Test Nasal Type Introduction
  2. 4.1.1 Colloidal Gold Immunochromatography
  3. 4.1.2 Latex Immunochromatography
  4. 4.1.3 Fluorescence Immunochromatography
  5. 4.1.4 Others
  6. 4.2 Global Antigen Self Test Nasal Sales Volume by Type
  7. 4.2.1 Global Antigen Self Test Nasal Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Antigen Self Test Nasal Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Antigen Self Test Nasal Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Antigen Self Test Nasal Sales Value by Type
  11. 4.3.1 Global Antigen Self Test Nasal Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Antigen Self Test Nasal Sales Value by Type (2021-2032)
  13. 4.3.3 Global Antigen Self Test Nasal Sales Value Share by Type (2021-2032)
5 Antigen Self Test Nasal Market by Application
  1. 5.1 Antigen Self Test Nasal Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 School
  4. 5.1.3 Family
  5. 5.1.4 Others
  6. 5.2 Global Antigen Self Test Nasal Sales Volume by Application
  7. 5.2.1 Global Antigen Self Test Nasal Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antigen Self Test Nasal Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Antigen Self Test Nasal Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Antigen Self Test Nasal Sales Value by Application
  11. 5.3.1 Global Antigen Self Test Nasal Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antigen Self Test Nasal Sales Value by Application (2021-2032)
  13. 5.3.3 Global Antigen Self Test Nasal Sales Value Share by Application (2021-2032)
6 Antigen Self Test Nasal Regional Sales and Value Analysis
  1. 6.1 Global Antigen Self Test Nasal Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antigen Self Test Nasal Sales by Region (2021-2032)
  3. 6.2.1 Global Antigen Self Test Nasal Sales by Region: 2021-2026
  4. 6.2.2 Global Antigen Self Test Nasal Sales by Region (2027-2032)
  5. 6.3 Global Antigen Self Test Nasal Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antigen Self Test Nasal Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antigen Self Test Nasal Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antigen Self Test Nasal Sales Value by Region (2027-2032)
  9. 6.5 Global Antigen Self Test Nasal Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antigen Self Test Nasal Sales Value (2021-2032)
  12. 6.6.2 North America Antigen Self Test Nasal Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antigen Self Test Nasal Sales Value (2021-2032)
  15. 6.7.2 Europe Antigen Self Test Nasal Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antigen Self Test Nasal Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antigen Self Test Nasal Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antigen Self Test Nasal Sales Value (2021-2032)
  21. 6.9.2 South America Antigen Self Test Nasal Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antigen Self Test Nasal Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antigen Self Test Nasal Sales Value Share by Country, 2025 VS 2032
7 Antigen Self Test Nasal Country-level Sales and Value Analysis
  1. 7.1 Global Antigen Self Test Nasal Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antigen Self Test Nasal Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antigen Self Test Nasal Sales by Country (2021-2032)
  4. 7.3.1 Global Antigen Self Test Nasal Sales by Country (2021-2026)
  5. 7.3.2 Global Antigen Self Test Nasal Sales by Country (2027-2032)
  6. 7.4 Global Antigen Self Test Nasal Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antigen Self Test Nasal Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antigen Self Test Nasal Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antigen Self Test Nasal Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antigen Self Test Nasal Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antigen Self Test Nasal Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Antigen Self Test Nasal Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Watsons
  8. 8.2.1 Watsons Company Information
  9. 8.2.2 Watsons Business Overview
  10. 8.2.3 Watsons Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Watsons Antigen Self Test Nasal Product Portfolio
  12. 8.2.5 Watsons Recent Developments
  13. 8.3 TEST SEA LAB
  14. 8.3.1 TEST SEA LAB Company Information
  15. 8.3.2 TEST SEA LAB Business Overview
  16. 8.3.3 TEST SEA LAB Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TEST SEA LAB Antigen Self Test Nasal Product Portfolio
  18. 8.3.5 TEST SEA LAB Recent Developments
  19. 8.4 SD Biosensor
  20. 8.4.1 SD Biosensor Company Information
  21. 8.4.2 SD Biosensor Business Overview
  22. 8.4.3 SD Biosensor Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 SD Biosensor Antigen Self Test Nasal Product Portfolio
  24. 8.4.5 SD Biosensor Recent Developments
  25. 8.5 RapiGEN Inc.
  26. 8.5.1 RapiGEN Inc. Company Information
  27. 8.5.2 RapiGEN Inc. Business Overview
  28. 8.5.3 RapiGEN Inc. Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 RapiGEN Inc. Antigen Self Test Nasal Product Portfolio
  30. 8.5.5 RapiGEN Inc. Recent Developments
  31. 8.6 Rapid Labs Limited
  32. 8.6.1 Rapid Labs Limited Company Information
  33. 8.6.2 Rapid Labs Limited Business Overview
  34. 8.6.3 Rapid Labs Limited Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Rapid Labs Limited Antigen Self Test Nasal Product Portfolio
  36. 8.6.5 Rapid Labs Limited Recent Developments
  37. 8.7 Quidel
  38. 8.7.1 Quidel Company Information
  39. 8.7.2 Quidel Business Overview
  40. 8.7.3 Quidel Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Quidel Antigen Self Test Nasal Product Portfolio
  42. 8.7.5 Quidel Recent Developments
  43. 8.8 Princeton BioMeditech Corporation
  44. 8.8.1 Princeton BioMeditech Corporation Company Information
  45. 8.8.2 Princeton BioMeditech Corporation Business Overview
  46. 8.8.3 Princeton BioMeditech Corporation Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Princeton BioMeditech Corporation Antigen Self Test Nasal Product Portfolio
  48. 8.8.5 Princeton BioMeditech Corporation Recent Developments
  49. 8.9 Orient Gene
  50. 8.9.1 Orient Gene Company Information
  51. 8.9.2 Orient Gene Business Overview
  52. 8.9.3 Orient Gene Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Orient Gene Antigen Self Test Nasal Product Portfolio
  54. 8.9.5 Orient Gene Recent Developments
  55. 8.10 OraSure Technologies
  56. 8.10.1 OraSure Technologies Company Information
  57. 8.10.2 OraSure Technologies Business Overview
  58. 8.10.3 OraSure Technologies Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 OraSure Technologies Antigen Self Test Nasal Product Portfolio
  60. 8.10.5 OraSure Technologies Recent Developments
  61. 8.11 LumiraDx
  62. 8.11.1 LumiraDx Company Information
  63. 8.11.2 LumiraDx Business Overview
  64. 8.11.3 LumiraDx Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 LumiraDx Antigen Self Test Nasal Product Portfolio
  66. 8.11.5 LumiraDx Recent Developments
  67. 8.12 InBios
  68. 8.12.1 InBios Company Information
  69. 8.12.2 InBios Business Overview
  70. 8.12.3 InBios Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 InBios Antigen Self Test Nasal Product Portfolio
  72. 8.12.5 InBios Recent Developments
  73. 8.13 Heathershaws Compounding Pharmacy
  74. 8.13.1 Heathershaws Compounding Pharmacy Company Information
  75. 8.13.2 Heathershaws Compounding Pharmacy Business Overview
  76. 8.13.3 Heathershaws Compounding Pharmacy Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Heathershaws Compounding Pharmacy Antigen Self Test Nasal Product Portfolio
  78. 8.13.5 Heathershaws Compounding Pharmacy Recent Developments
  79. 8.14 Ellume
  80. 8.14.1 Ellume Company Information
  81. 8.14.2 Ellume Business Overview
  82. 8.14.3 Ellume Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Ellume Antigen Self Test Nasal Product Portfolio
  84. 8.14.5 Ellume Recent Developments
  85. 8.15 CTK Biotech
  86. 8.15.1 CTK Biotech Company Information
  87. 8.15.2 CTK Biotech Business Overview
  88. 8.15.3 CTK Biotech Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CTK Biotech Antigen Self Test Nasal Product Portfolio
  90. 8.15.5 CTK Biotech Recent Developments
  91. 8.16 Clip Health
  92. 8.16.1 Clip Health Company Information
  93. 8.16.2 Clip Health Business Overview
  94. 8.16.3 Clip Health Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Clip Health Antigen Self Test Nasal Product Portfolio
  96. 8.16.5 Clip Health Recent Developments
  97. 8.17 Celltrion
  98. 8.17.1 Celltrion Company Information
  99. 8.17.2 Celltrion Business Overview
  100. 8.17.3 Celltrion Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Celltrion Antigen Self Test Nasal Product Portfolio
  102. 8.17.5 Celltrion Recent Developments
  103. 8.18 BioTeke Corporation
  104. 8.18.1 BioTeke Corporation Company Information
  105. 8.18.2 BioTeke Corporation Business Overview
  106. 8.18.3 BioTeke Corporation Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 BioTeke Corporation Antigen Self Test Nasal Product Portfolio
  108. 8.18.5 BioTeke Corporation Recent Developments
  109. 8.19 BGI
  110. 8.19.1 BGI Company Information
  111. 8.19.2 BGI Business Overview
  112. 8.19.3 BGI Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 BGI Antigen Self Test Nasal Product Portfolio
  114. 8.19.5 BGI Recent Developments
  115. 8.20 BD
  116. 8.20.1 BD Company Information
  117. 8.20.2 BD Business Overview
  118. 8.20.3 BD Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 BD Antigen Self Test Nasal Product Portfolio
  120. 8.20.5 BD Recent Developments
  121. 8.21 Aidian Oy
  122. 8.21.1 Aidian Oy Company Information
  123. 8.21.2 Aidian Oy Business Overview
  124. 8.21.3 Aidian Oy Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Aidian Oy Antigen Self Test Nasal Product Portfolio
  126. 8.21.5 Aidian Oy Recent Developments
  127. 8.22 ACCESS BIO
  128. 8.22.1 ACCESS BIO Company Information
  129. 8.22.2 ACCESS BIO Business Overview
  130. 8.22.3 ACCESS BIO Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 ACCESS BIO Antigen Self Test Nasal Product Portfolio
  132. 8.22.5 ACCESS BIO Recent Developments
  133. 8.23 Abbott
  134. 8.23.1 Abbott Company Information
  135. 8.23.2 Abbott Business Overview
  136. 8.23.3 Abbott Antigen Self Test Nasal Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Abbott Antigen Self Test Nasal Product Portfolio
  138. 8.23.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antigen Self Test Nasal Value Chain Analysis
  2. 9.1.1 Antigen Self Test Nasal Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antigen Self Test Nasal Sales Mode & Process
  6. 9.2 Antigen Self Test Nasal Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antigen Self Test Nasal Distributors
  9. 9.2.3 Antigen Self Test Nasal Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst